# Immunology Core

> **NIH NIH U19** · GEORGIA STATE UNIVERSITY · 2022 · $270,000

## Abstract

This Core component will take advantage of our established vaccine evaluation pipeline, which includes our 
innovative high throughput approaches facilitate our antigen engineering efforts by simultaneously allowing the 
reactivity of antiserum to be measured against all known antigenic variants of a given protein, and our 
humanized mouse-based infection models, which allow us to test the protective efficacy of vaccines during 
gonococcal asymptomatic colonization and disease. The results generated by this Core are central to vaccine 
design and formulation efforts being undertaken in Projects 1 and 2, and will be used to inform the vaccine 
impact modeling being performed in Project 3.

## Key facts

- **NIH application ID:** 10355469
- **Project number:** 5U19AI144182-04
- **Recipient organization:** GEORGIA STATE UNIVERSITY
- **Principal Investigator:** SCOTT D GRAY-OWEN
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $270,000
- **Award type:** 5
- **Project period:** 2019-03-25 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10355469

## Citation

> US National Institutes of Health, RePORTER application 10355469, Immunology Core (5U19AI144182-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10355469. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*